CRYOPORT, INC. Payments to Acquire Businesses, Gross
CRYOPORT, INC. (CYRX) reported Payments to Acquire Businesses, Gross of $6.55 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2023-11-09
- 2022-07-31: Payments to Acquire Businesses, Gross 1 month 1.40M EUR.
EUR
| Period end | Payments to Acquire Businesses, Gross 1 month |
|---|---|
| 2022-07-31 | 1.40M EUR 10-K · filed 2023-02-28 |
USD
| Period end | Payments to Acquire Businesses, Gross 1 month | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month |
|---|---|---|---|---|
| 2022-09-30 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $6.55M 10-Q · filed 2023-11-09 | ||
| 2022-07-31 | $1.40M 10-K · filed 2023-02-28 | |||
| 2022-06-30 | $2.11M 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |